Skip to main content
. 2024 Mar 1;14(3):280. doi: 10.3390/jpm14030280

Table 1.

Baseline characteristics of participants with type 2 diabetes mellitus in low (L) and high (H) groups of fasting plasma GLP-1 levels.

Variable Fasting Plasma GLP-1 (pmol/L) p-Value
Group L
(<1.83)
n = 34
Group H
(1.83–3.32)
n = 34
Total
n = 68
Age (years) 59.3 ± 9.8 56.7 ± 10.0 58.8 ± 9.9 0.291
Men, n (%) 26 (76.5) 17 (50.0) 43 (63.2) 0.044
Systolic BP (mmHg) 131.3 ± 15.9 127.8 ± 11.9 129.5 ± 14.0 0.326
Diastolic BP (mmHg) 74.5 ± 11.2 76.4 ± 10.9 75.4 ± 11.0 0.493
Body mass index (kg/m2) 26.0 ± 3.4 25.2 ± 5.3 25.6 ± 4.4 0.505
Waist circumference (cm) 92.0 ± 8.6 93.0 ± 10.4 92.5 ± 9.4 0.754
Total cholesterol (mg/dL) 156.0 ± 31.3 169.6 ± 34.3 162.8 ± 33.3 0.093
HDL cholesterol (mg/dL) 46.9 ± 8.0 47.9 ± 10.7 47.4 ± 9.4 0.656
LDL cholesterol (mg/dL) 75.6 ± 17.7 82.7 ± 18.4 79.2 ± 18.3 0.109
Triglycerides (mg/dL) 148.5 (110.0–198.0) 160.0 (110.0–217.0) 155.0 (110.0–212.0) 0.840
Duration of diabetes (months) 121.9 ± 91.2 84.4 ± 79.4 102.9 ± 86.8 0.086
HbA1c (%) 8.3 ± 2.1 7.7 ± 1.5 8.0 ± 1.9 0.132
Fasting plasma glucose (mg/dL) 200.1 ± 78.5 177.0 ± 79.5 188.5 ± 79.3 0.231
Fasting insulin (uIU/mL) 12.9 (5.9–22.2) 20.0 (8.1–32.9) 14.5 (7.5–29.8) 0.130
HOMA-IR 5.4 (2.8–13.5) 10.9 (3.3–17.0) 6.7 (3.0–14.3) 0.275
HOMA-β (%) 27.4 (16.6–68.7) 41.9 (17.0–85.1) 32.7 (17.0–84.7) 0.448
Estimated GFR (mL/min/1.73 m2) 90.9 ± 27.9 103.6 ± 27.2 97.3 ± 28.1 0.079
Creatinine (mg/dL) 0.9 ± 0.4 0.7 ± 0.3 0.8 ± 0.3 0.040
hs-CRP (mg/dL) 0.4 (0.2–1.1) 0.9 (0.3–1.7) 0.5 (0.2–1.4) 0.067
GLP-1 (pmol/L) 1.4 ± 0.3 2.5 ± 0.5 2.0 ± 0.6 <0.001
UACR (mg/g) 55.0 (0.0–470.0) 10.0 (0.0–60.0) 10.0 (0.0–195.0) 0.036
Albuminuria, n (%) 20 (58.8) 11 (32.4) 31 (45.6) 0.051

Continuous variables with normal distributions are expressed as mean ± standard deviation, whereas continuous variables with non-normal distributions are expressed as median (interquartile range). Categorical variables are expressed as percentages (%). Abbreviations: GLP-1, glucagon-like peptide-1; BP, blood pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; HOMA-IR, homeostatic model assessment for insulin resistance; HOMA-β, homeostasis model assessment of β-cell function; GFR, glomerular filtration rate; hs-CRP, high-sensitivity C-reactive protein; UACR, urine albumin creatinine ratio.